Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
883 studies found for:    "Hypercholesterolemia"
Show Display Options
Rank Status Study
21 Completed A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesteremia
Condition: Hypercholesterolemia
Interventions: Drug: Enteric coated sevelamer;   Drug: Colesevelam Cholestagel;   Drug: Placebo
22 Completed A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: HS-25;   Drug: Placebo
23 Unknown  Trial to Assess the Effects of P-OM3 on LDL-C in Subjects With Primary Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: P-OM3;   Drug: Placebo
24 Terminated Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: Lapaquistat acetate;   Drug: Placebo
25 Recruiting Efficacy of a Red Yeast Rice Based Nutraceutical Plus Probiotic in Patients With Moderate Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Dietary Supplement: Lactoflorene colesterolo;   Dietary Supplement: Placebo lactoflorene colesterolo
26 Unknown  Study of Awareness and Detection of Familial Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
27 Unknown  Effect of Plant Sterols on the Lipid Profile of Patients With Hypercholesterolaemia
Condition: Hypercholesterolemia
Intervention: Dietary Supplement: Plant stanol esters
28 Recruiting French Observatory of Familial Hypercholesterolemia in Cardiology
Condition: Familial Hypercholesterolemia
Intervention:
29 Completed Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention: Drug: MD-0727
30 Terminated Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy
Condition: Familial Hypercholesterolemia
Intervention: Drug: Implitapide
31 Completed LIP-01 in Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention: Dietary Supplement: LIP-01
32 Terminated Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy
Condition: Familial Hypercholesterolemia
Intervention: Drug: Implitapide
33 Withdrawn Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients
Condition: Familial Hypercholesterolemia
Interventions: Drug: APL180;   Drug: Placebo
34 Recruiting Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe
Condition: Hypercholesterolemia
Intervention: Drug: Rosuvastatin and Ezetimibe morning or evening administration
35 Recruiting The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Condition: Homozygous Familial Hypercholesterolemia
Intervention:
36 Completed A Trial to Evaluate the Efficacy of AB-Life Probiotic Product on LDL-Cholesterol Reduction in Moderate Hypercholesterolemia
Condition: Moderate Hypercholesterolemia
Intervention: Dietary Supplement: Probiotics bacterial strains
37 Recruiting The Spanish Familial Hypercholesterolaemia Cohort Study
Condition: Familial Hypercholesterolaemia
Intervention:
38 Completed InPractice Survey on the Treatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
39 Completed
Has Results
An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia
Condition: Familial Hypercholesterolaemia
Intervention: Drug: rosuvastatin calcium
40 Completed Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin;   Drug: Simvastatin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.